Seasonal variation in biopsy-proven giant cell arteritis in Eastern Denmark from 1990-2018.
arteritis temporalis
giant cell arteritis
seasonal variation
seasonality
Journal
Acta ophthalmologica
ISSN: 1755-3768
Titre abrégé: Acta Ophthalmol
Pays: England
ID NLM: 101468102
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
revised:
01
10
2020
received:
08
05
2020
accepted:
11
10
2020
pubmed:
20
11
2020
medline:
15
12
2021
entrez:
19
11
2020
Statut:
ppublish
Résumé
The purpose of this study was to investigate seasonal variation in cases of biopsy-proven GCA in eastern Denmark in a 29-year period. Pathology records of all temporal artery biopsies in eastern Denmark between 1990 and 2018 were reviewed. For each patient, data were collected which included age, sex, date of birth and biopsy result. Seasonality was evaluated using logistic regression and Poisson regression analysis. Lastly, an explorative pilot study was conducted to investigate a possible association between three weather parameters (average temperature, amount of rain and hours of sunshine) and the biopsy outcome. One thousand three hundred twenty-three biopsies were included of which 336 fulfilled objective criteria for GCA diagnosis. Mean age at diagnosis was 75.6 years (range 52-94 years). Among the biopsy-proven cases of GCA, there were 223 women (66.3%, mean age 76.2 years) and 113 men (33.7%, mean age 74.4 years) giving a female to male ratio of 1.97:1. The peak occurrence of GCA was in the 70-79 years age group. Statistical analysis of seasonal variation showed an increased risk of a positive biopsy during summer compared to autumn (p = 0.037). No association between the three weather parameters and the biopsy outcome was found. In this study of biopsy-proven GCA in a large Danish patient cohort, the occurrence of GCA showed seasonal variation with higher occurrence in the summer months when compared to autumn. Future studies pooling all cases of GCA worldwide are needed to determine seasonality in the occurrence of GCA.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
527-532Informations de copyright
© 2020 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.
Références
Abdul-Rahman AM, Molteno AC & Bevin TH (2011): The epidemiology of giant cell arteritis in Otago, New Zealand: a 9-year analysis. N Zeal Med J (Online) 124: 44-52.
Bas-Lando M, Breuer G, Berkun Y, Mates M, Sonnenblick M & Nesher G (2007): The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations. Clin Exp Rheumatol 25: S15-17.
Borchers AT & Gershwin ME (2012): Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment. Autoimmun Rev 11: A544-554.
Carmona FD, Mackie SL, Martin JE et al. (2015): A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility. Am J Hum Genet 96: 565-580.
Catanoso M, Macchioni P, Boiardi L et al. (2017): Incidence, prevalence, and survival of biopsy-proven giant cell arteritis in Northern Italy during a 26-year period. Arthritis Care Res (Hoboken) 69: 430-438.
De Smit E, Clarke L, Sanfilippo PG, Merriman TR, Brown MA, Hill CL & Hewitt AW (2017): Geo-epidemiology of temporal artery biopsy-positive giant cell arteritis in Australia and New Zealand: is there a seasonal influence? RMD Open 3: e000531.
Duhaut P, Pinède L, Bornet H, Demolombe-Ragué S, Dumontet C, Ninet J, Loire R & Pasquier J (1999): Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease. Ann Rheum Dis 58: 335-341.
Dunstan E, Lester SL, Rischmueller M et al. (2014): Epidemiology of biopsy-proven giant cell arteritis in South Australia. Intern Med J 44: 32-39.
Elling P, Olsson A & Elling H (1996): Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection. J Rheumatol 23: 112-119.
Gilden D, White T, Khmeleva N, Boyer PJ & Nagel MA (2016): VZV in biopsy-positive and -negative giant cell arteritis: Analysis of 100+ temporal arteries. Neurol Neuroimmunol Neuroinflamm 3: e216.
Gokoffski KK, Chatterjee A & Khaderi SK (2019): Seasonal incidence of biopsy-proven giant cell arteritis: a 20-year retrospective study of the University of California Davis Medical System. Clin Exp Rheumatol 37: 90-97.
Gonzalez-Gay MA, Miranda-Filloy JA, Lopez-Diaz MJ, Perez-Alvarez R, Gonzalez-Juanatey C, Sanchez-Andrade A, Martin J & Llorca J (2007): Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study. Medicine (Baltimore) 86: 61-68.
Hunder GG, Bloch DA, Michel BA et al. (1990): The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33: 1122-1128.
Ing EB, Ing R, Liu X, Zhang A, Torun N, Sey M & Pagnoux C (2018): Does herpes zoster predispose to giant cell arteritis: a geo-epidemiologic study. Clin Ophthalmol 12: 113-118.
Kisza K, Murchison AP, Dai Y, Bilyk JR, Eagle RC Jr, Sergott R & Savino PJ (2013): Giant cell arteritis incidence: analysis by season and year in mid-Atlantic United States. Clin Exp Ophthalmol 41: 577-581.
Lester S, Hewitt AW, Ruediger CD et al. (2016): PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis. RMD Open 2: e000246.
Llorca J, Bringas-Bollada M, Garcia-Porrua C & Gonzalez-Gay MA (2005): Altitude and giant cell arteritis. J Rheumatol 32: 963-964.
Mohammad AJ, Nilsson JA, Jacobsson LT, Merkel PA & Turesson C (2015): Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden. Ann Rheum Dis 74: 993-997.
Niederkohr RD & Levin LA (2007): A Bayesian analysis of the true sensitivity of a temporal artery biopsy. Invest Ophthalmol Vis Sci 48: 675-680.
Pamuk Ö, Dönmez S, Karahan B, Pamuk G & Cakir N (2009): Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data. Clin Exp Rheumatol 27: 830.
Perfetto F, Moggi-Pignone A, Becucci A, Cantini F, Di Natale M, Livi R, Tempestini A & Matucci-Cerinic M (2005): Seasonal pattern in the onset of polymyalgia rheumatica. Ann Rheum Dis 64: 1662-1663.
Peris P (2003): Polymyalgia rheumatica is not seasonal in pattern and is unrelated to parvovirus b19 infection. J Rheumatol 30: 2624-2626.
Petursdottir V, Johansson H, Nordborg E & Nordborg C (1999): The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations. Rheumatology 38: 1208-1212.
Pucelj NP, Hocevar A, Jese R, Rotar Z, Hawlina M, Fakin A, Pizem J & Tomsic M (2019): The incidence of giant cell arteritis in Slovenia. Clin Rheumatol 38: 285-290.
Samson M, Corbera-Bellalta M, Audia S, Planas-Rigol E, Martin L, Cid MC & Bonnotte B (2017): Recent advances in our understanding of giant cell arteritis pathogenesis. Autoimmun Rev 16: 833-844.
Smeeth L, Cook C & Hall AJ (2006): Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001. Ann Rheum Dis 65: 1093-1098.